SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+9.85%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$474M
AUM Growth
+$474M
Cap. Flow
+$164M
Cap. Flow %
34.54%
Top 10 Hldgs %
94.15%
Holding
20
New
4
Increased
1
Reduced
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$106M 22.33% 12,850,000
ABBV icon
2
AbbVie
ABBV
$372B
$92.5M 19.51% +1,580,000 New +$92.5M
DGX icon
3
Quest Diagnostics
DGX
$20.3B
$59.6M 12.56% 775,000
AMGN icon
4
Amgen
AMGN
$155B
$50.8M 10.72% 318,000
AEGR
5
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$42.9M 9.04% +1,637,455 New +$42.9M
MDCO
6
DELISTED
Medicines Co
MDCO
$34M 7.18% +1,215,100 New +$34M
MRK icon
7
Merck
MRK
$210B
$23M 4.85% 400,000
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
$15.7M 3.32% +875,000 New +$15.7M
SEEL
9
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$12.2M 2.57% 6,524,505 +5,494,505 +533% +$10.3M
RPRX
10
DELISTED
Repros Therapeutics Inc.
RPRX
$9.73M 2.05% 1,132,367
ITCI
11
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.6M 1.81% 360,000
VVUS
12
DELISTED
Vivus Inc
VVUS
$6.33M 1.34% 2,573,943
KIN
13
DELISTED
Kindred Biosciences, Inc.
KIN
$4.92M 1.04% 689,091
AVEO
14
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$3.73M 0.79% 2,570,759
ANIP icon
15
ANI Pharmaceuticals
ANIP
$2.03B
$1.94M 0.41% 31,000
GYRE icon
16
Gyre Therapeutics
GYRE
$703M
$1.87M 0.39% 630,000
CARM icon
17
Carisma Therapeutics
CARM
$8.98M
$368K 0.08% 41,200
A icon
18
Agilent Technologies
A
$35.7B
-460,000 Closed -$18.8M
CYCC icon
19
Cyclacel Pharmaceuticals
CYCC
$18.4M
-376,000 Closed -$263K
BRLI
20
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
-390,270 Closed -$12.5M